StockData
Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc. (ABEO) stock

ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3027% below fair value
$2.73+0.13 (+5.00%)

Close on Nov 18, 2026Market cap $156.11MP/E –Yield –

Abeona Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Abeona Therapeutics's price to sales ratio was 5.2× on Nov 11, 2026, against 52.3× a year earlier. Over the last 5 years it ranged from 1.9× to 465.0×, with a median of 53.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.2×−26.2
2024Apr 30, 202431.4×−7.1
2023Apr 28, 202338.5×+21.5
2021Apr 30, 202117.0×−36.3
2019Oct 31, 201953.3×−69.4
2018Dec 31, 2018122.7×−240.0
2017Jul 31, 2017362.7×+174.6
2016Dec 30, 2016188.2×+186.2
2015Jan 30, 20151.9×−0.2
2014Dec 31, 20142.1×−0.1
2013Dec 31, 20132.2×+0.7
2012Dec 31, 20121.5×–

More Abeona Therapeutics figures

See a number that looks wrong?